Merus has formed product candidate, technology and antibody discovery collaborations with top tier pharmaceutical and biotechnology companies. Collaborations are a key part of our business strategy and thus we are actively seeking new collaborations with companies who are interested in licensing our product candidates and proprietary technologies. Merus is also seeking collaborations to develop novel antibody therapeutics in a range of disease areas.
Here you can find more information regarding our current collaborators. If you are interested in learning more, please leave your contact details and brief description of your collaboration request below.
Merus strives to carefully build a portfolio of pipeline programs using our Biclonics ® technology platform. In conjunction with our internal research and development, we seek potential partners or collaborators to help extend the reach and capabilities of our technology platform and product candidates.
We have a robust platform for generating high-quality, bispecific antibodies, and we are open to working with academic institutions and other industry collaborators. Our ability to do high-throughput functional screening permits us to explore interesting areas of biology by quickly generating bispecific antibodies binding different target pairs and, with the right functional assays, helps us to identify the best candidates to pursue.